Nupsala is now licensed to sell controlled drugs, which marks a significant expansion of the firm’s product range which includes UK-licensed human and veterinary pharmaceuticals.
Greg McGarrell, managing director, comments: “This new offering reflects Nupsala’s ongoing commitment to supporting veterinary professionals with the essential products required for top-quality patient care. With a focus on musculoskeletal solutions and regenerative medicine, Nupsala continues to deliver the comprehensive resources needed to help veterinary practices thrive.”
Comments